High-fat diet induced adiposity and insulin resistance in mice lacking the myotonic dystrophy protein kinase

FEBS Letters

Volumn 583, Issue 12, 2009, Pages 2121-2125

  Llagostera, Esther ^a   Carmona, Mari Carmen ^a   Vicente, Meritxell ^a   Escorihuela, Rosa María ^b   Kaliman, Perla ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Diabetes; Diet; DMPK; Insulin resistance; Myotonic dystrophy 1; Obesity

Indexed keywords

INSULIN; MYOTONIC DYSTROPHY PROTEIN KINASE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ENZYME DEFICIENCY; GENE INTERACTION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HYPERTROPHY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIFESTYLE; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SITTING; WEIGHT GAIN; WILD TYPE;

ADIPOCYTES; ADIPOSITY; ANIMALS; CELL ENLARGEMENT; DIETARY FATS; DISEASE MODELS, ANIMAL; HUMANS; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; MYOTONIC DYSTROPHY; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; WEIGHT GAIN;

MUS;

EID: 67349121299     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.05.043     Document Type: Article

References (29)

1. Harper P.S. Myotonic Dystrophy. 3rd ed. (2001), WB Saunders, London
2. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy-expansion of a trinucleotide CTG repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68 (1992) 799-808
3. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 255 (1992) 1253-1255
4. Jansen G., Mahadevan M., Amemiya C., Wormskamp N., Segers B., Hendriks W., O'Hoy K., Baird S., Sabourin L., Lennon G., et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat. Genet. 1 (1992) 261-266
5. Fu Y.H., Pizzuti A., Fenwick Jr. R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255 (1992) 1256-1258
6. Machuca-Tzili L., Brook D., and Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve. 32 (2005) 1-18
7. Wansink D.G., and Wieringa B. Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenet. Genome Res. 100 1-4 (2003) 230-242
8. Reddy S., Smith D.B., Rich M.M., Leferovich J.M., Reilly P., Davis B.M., Tran K., Rayburn H., Bronson R., Cros D., et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 13 (1996) 325-335
9. Jansen G., Groenen P.J., Bachner D., Jap P.H., Coerwinkel M., Oerlemans F., van den Broek W., Gohlsch B., Pette D., Plomp J.J., et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 13 (1996) 316-324
10. Berul C.I., Maguire C.T., Aronovitz M.J., Greenwood J., Miller C., Gehrmann J., Housman D., Mendelsohn M.E., and Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest. 103 (1999) R1-R7
11. Kaliman P., and Llagostera E. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1. Cell. Signal. 20 (2008) 1935-1941
12. Biddinger S.B., and Kahn C.R. From mice to men: Insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68 (2006) 123-158
13. Krentz A.J., Clark P.M., Cox L., Williams A.C., and Nattrass M. Hyperproinsulinaemia in patients with myotonic dystrophy. Diabetologia 35 (1992) 1170-1172
14. Vialettes B., Pouget J., Viard R., Moulin J.P., Serratrice G., and Vaque P. Mechanism and significance of insulin resistance in myotonic dystrophy. Horm. Metab. Res. 18 (1986) 395-399
15. Moxley R.T., Corbett A.J., Minaker K.L., and Rowe J.W. Whole body insulin resistance in myotonic dystrophy. Ann. Neurol. 15 (1984) 157-162
16. Moxley III R.T., Griggs R.C., Goldblatt D., VanGelder V., Herr B.E., and Thiel R. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J. Clin. Invest. 62 (1978) 857-867
17. Moorjani S., Gaudet D., Laberge C., Thibault M.C., Mathieu J., Morissette J., Lupien P.J., Brun D., and Gagné C. Hypertriglyceridemia and lower LDL cholesterol concentration in relation to apolipoprotein E phenotypes in myotonic dystrophy. Can. J. Neurol. Sci. 16 (1989) 129-133
18. Fernández-Real J.M., Molina A., Broch M., Ricart W., Gutiérrez C., Casamitjana R., Vendrell J., Soler J., and Gómez-Sáez J.M. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes 48 (1999) 1108-1112
19. Gómez J.M., Molina A., Férnandez-Castañer M., Casamitjana R., Martínez-Matos J.A., and Soler J. Insulin regulation of leptin synthesis and secretion in humans: The model of myotonic dystrophy. Clin. Endocrinol. 50 (1999) 569-575
20. Perseghin G., Comola M., Scifo P., Benedini S., De Cobelli F., Lanzi R., Costantino F., Lattuada G., Battezzati A., Del Maschio A., and Luzi L. Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. Am. J. Clin. Nutr. 80 (2004) 357-364
21. Nozaki S., Miyai I., and Kang J. Intra-abdominal visceral fat in myotonic dystrophy. Rinsho Shinkeigaku. 32 (1992) 521-523
22. Johansson A., Andrew R., Forsberg H., Cederquist K., Walker B.R., and Olsson T. Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy. J. Clin. Endocrinol. Metab. 86 (2001) 4276-4283
23. Rodríguez-Sureda V., and Peinado-Onsurbe J. A procedure for measuring triacylglyceride and cholesterol content using small amount of tissue. Anal. Biochem. 343 (2005) 277-282
24. Fernández-Alvarez J., Barberà A., Nadal B., Barceló-Batllori S., Piquer S., Claret M., Guinovart J.J., and Gomis R. Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia 47 (2004) 470-477
25. Llagostera E., Catalucci D., Marti L., Liesa M., Camps M., Ciaraldi T.P., Kondo R., Reddy S., Dillmann W.H., Palacin, et al. Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. PLoS ONE 2 (2007) e1134
26. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106 (2000) 171-176
27. Zhou Y.P., and Grill V. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metab. 80 (1995) 1584-1590
28. Shimabukuro M., Zhou Y.T., Levi M., and Unger R.H. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 95 (1998) 2498-2502
29. LeRoith D. Dyslipidemia and glucose dysregulation in overweight and obese patients. Clin. Cornerstone. 8 (2007) 38-52